• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Five modifiable risk factors contribute to cardiovascular disease and mortality

byDavid XiangandKiera Liblik
December 11, 2023
in Cardiology, Chronic Disease, Public Health
Reading Time: 2 mins read
Rilonacept may lower pericarditis recurrence in patients with relapsing pericarditis
Share on FacebookShare on Twitter

1. In this retrospective cohort study, five risk factors (body mass index, systolic blood pressure, non–high-density lipoprotein cholesterol, current smoking, and diabetes) contributed to increased incidence of cardiovascular disease. 

2. These factors were also noted to increase the risk of death from any cause.

Evidence Rating Level: 2 (Good)

Study Rundown: Modifiable risk factors such as body mass index, systolic blood pressure, non–high-density lipoprotein cholesterol, smoking status, and diabetes have been used to derive contemporary risk scores for the estimation of the 10-year risk of cardiovascular disease, though they are given different weights. However, there is a gap in knowledge as to understanding the region- and sex-specific associations of these cardiovascular risk factors with the development of cardiovascular disease, which can ultimately help reduce the burden of cardiovascular disease and death from any cause for persons and populations. Overall, this study found that 57.2% and 52.6% of cases of incident cardiovascular disease among women and men, respectively, and 22.2% and 19.1% of deaths from any cause among women and men, respectively, may be attributable to five modifiable risk factors. This study was limited by residual confounding and the categorization of geographic regions being defined by the World Health Organization, whereas different categorization schemas may produce different results. Nevertheless, these study’s findings are significant, as they demonstrate that these five modifiable risk factors are strongly associated with incident cardiovascular disease and death from any cause.

Click to read the study in NEJM

In-Depth [retrospective cohort study]: This retrospective cohort study utilized patient-level data from 112 cohort studies conducted in 34 countries and eight geographic regions participating in the Global Cardiovascular Risk Consortium. Patients who were included in the prior studies were eligible for the study, whereas patients excluded from the prior studies were excluded from this study. Five risk factors (body mass index, systolic blood pressure, non-HDL cholesterol, current smoking status, and diabetes) and two primary outcomes (cardiovascular disease and death from any cause) were assessed in the study because of the heterogeneity of the effects of the risk factors on outcomes and the widespread availability of these data in the population. Outcomes in the primary analysis were assessed via a two-stage, multivariate, random effects meta-analysis of individual participant data. Based on the primary analysis, 80,596 participants experienced incident cardiovascular disease after a median follow-up of 7.3 years (maximum, 47.3), and 177,369 participants experienced death after a median follow-up of 8.7 years (maximum, 47.6). The aggregate global population-attributable fraction of the 10-year incidence of cardiovascular disease was 57.2% (95% Confidence Interval [CI], 52.4 to 62.1) among women and 52.6% (95% CI, 49.0 to 56.1) among men after accounting for all 5 risk factors. Furthermore, the 10-year all-cause mortality was 22.2% (95% CI, 16.8 to 27.5) and 19.1% (95% CI, 14.6 to 23.6) for women and men, respectively. Overall, this study showed that these five modifiable risk factors are strongly associated with cardiovascular disease and death from any cause among men and women.

RELATED REPORTS

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

Chronic exposure to particulate matter is associated with increased cardiovascular risk

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: body mass indexcardiologycardiovascular diseasechronic diseasecurrent smokingdiabetesnon–high-density lipoprotein cholesterolpublic healthsystolic blood pressure
Previous Post

Tiragolumab With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage SCLC

Next Post

Several nutrients may be associated with improved cognitive function later in life

RelatedReports

Behavioral dysregulation in infancy predicts later child mental health
Cardiology

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

September 12, 2026
Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Endocrinology

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

September 10, 2026
Adalimumab aids in control of noninfectious uveitis
Chronic Disease

Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes

September 8, 2026
Next Post
Poor olfaction linked to increased mortality in older adults

Several nutrients may be associated with improved cognitive function later in life

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!

The Scan by 2 Minute Medicine®: Curbing Cravings with Zepbound, Tales of Transplants, New Gonorrhea Treatment, and Preterm Problems

#VisualAbstract: Early endovascular thrombectomy improves functional outcomes in large infarct ischaemic stroke

#VisualAbstract: Early endovascular thrombectomy improves functional outcomes in large infarct ischaemic stroke

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Male sex is associated with higher mortality among patients with hepatocellular carcinoma
  • Artificial intelligence (AI)-supported symptom self-assessment led to more appropriate patient care-seeking decisions
  • Rimegepant (Nurtec ODT) may be an effective alternative to triptans for symptom relief in migraines
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.